Business - Briefly   

Ranbaxy gets final FDA nod

NEW DELHI, JUNE 22. Ranbaxy today announced that it had got final approval from the U.S. Food and Drug Administration (USFDA) to market its Metformin HC1 tablets for diabetes. The approval was granted after Barr Laboratories, a wholly owned subsidiary of Barr Pharmaceuticals Inc., selectively waived its rights to their exclusivity in favour of Ranbaxy, says a company release.

— PTI

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts: Classifieds | Employment | Obituary | Updates: Breaking News |

Stories in this Section

• Indian firms' revenue up 29 p.c.
• TCS tops list with $1 b earnings
• Rupee tumbles to 11-month low
• Rangarajan for gradual move to capital account convertibility
• Market ends flat
• Intel's digital home initiative
• VSNL pays 45 p.c.
• Electrolux to invest in R&D centre
• ONGC profit dips to Rs. 8,664 cr.
• Banks to bring in more farmers under agri-credit
• Bullion rates
• Exchange rates
• Financial Times takes stake in Business Standard
• Ranbaxy gets final FDA nod
• Domestic leased line tariff
• Investment pattern for RNBCs
• Full exemption for export profits sought
• Biocon's Cuban JV expands product base
• NCR Corporation bags order for 50 ATMs
• Oracle to launch ISV Forum

Copyright © 2004, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu